Neostem Inc., of New York, filed a prospectus supplement to its shelf registration with the SEC enabling it to sell up to $30 million in shares of common stock to Aspire Capital Fund LLC subject to certain conditions over a two-year period. As of the March 31, Neostem had about $41 million in cash to fund operations.